MedPath
NMPA Approval

Prucalopride Succinate Tablets

国药准字H20183482

October 7, 2023

Drug Information

琥珀酸普芦卡必利片

瑞宜生

片剂

按C₁₈H₂₆ClN₃O₃计 2mg

化学药品

October 7, 2023

Company Information

Applicant Company

江苏省连云港经济技术开发区

Manufacturing Company

连云港经济技术开发区东晋路5号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

琥珀酸普芦卡必利片 - NMPA 批准文号 | MedPath